There is no cure, but the disease can be managed with pharmacologic therapies, among other more invasive treatments, that lower and stabilize intraocular pressure (IOP).
A fixed-dose tafluprost and timolol combination eye drop led to significant reductions in intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) and ocular hypertension (OHT)
